Results of a recent study strongly suggest simply getting more B vitamins in your diet could be a completely painless way of ...

A new study from McGill University challenges a decades-old belief about dopamine. Rather than driving movement like a ...

Houston-area clinical research organization Hope Biosciences Research Foundation (HBRF) today shares positive top-line results of a Phase II clinical trial to evaluate Hope Biosciences' allogeneic ...

Obstructive sleep apnea (OSA) may be associated with an increased risk of developing Parkinson disease, although early treatment with continuous positive airway pressure (CPAP) could help mitigate ...

Hope is preparing for close-out meetings with the FDA. Chang said the team is “hopeful to advance to a phase 3 confirmatory trial” of the stem cell therapy candidate.

A groundbreaking treatment for Parkinson’s disease and essential tremor is now available in Kentucky and the Norton ...

This therapy is one of a few drugs in mid-to-late-stage development for Parkinson’s that has displayed disease-modifying ...

ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GOTHENBURG, NE / ACCESS Newswire / December 23, 2025 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a ...

For decades, Parkinson’s disease has been framed as a straightforward story about dying brain cells and dwindling dopamine. A ...

Science Signaling retracted a 2017 paper that linked a specific amyloid form (amyloid-beta 56) to tau pathology after an ...

Detailed price information for Amneal Pharmaceuticals Inc (AMRX-Q) from The Globe and Mail including charting and trades.

As of Tuesday, December 23, Gain Therapeutics, Inc.’s GANX share price has surged by 7.37%, which has investors questioning if this is right time to sell.